PCOS: The Evidence-Based Supplement Protocol
Polycystic ovary syndrome is the most common endocrine disorder of reproductive-age women. The 2023 International PCOS Guideline endorses inositol as a non-pharmaceutical option for metabolic features. Among supplements, four have meaningful evidence: inositol combination, vitamin D, NAC, and omega-3.
Myo-Inositol + D-Chiro Inositol (40:1), 2 g + 50 mg Twice Daily
The 40:1 combination has the most consistent positive PCOS trial record. A 2017 meta-analysis of 9 RCTs found inositol improved insulin sensitivity (HOMA-IR), reduced free testosterone, and restored ovulation in 60–70% of treated women versus 20–30% in placebo. High-dose pure d-chiro alone can worsen oocyte quality and should be avoided. See our PCOS stack.
Vitamin D — Repletion to 30–50 ng/mL
Vitamin D deficiency is prevalent in PCOS (60–80% in published series). Repletion improves insulin sensitivity, lowers total testosterone, and improves menstrual regularity in deficient women. Dose to target serum level. See vitamin D piece.
N-Acetylcysteine (NAC), 1,800 mg Daily
Head-to-head trials of NAC 1,800 mg vs metformin 1,500 mg have shown comparable improvements in insulin sensitivity, ovulation rate, and androgen reduction. Reasonable first-line option for women who don't tolerate metformin. See our NAC piece.
EPA-Dominant Omega-3, 1.5–3 g Daily
Omega-3 modestly reduces free testosterone, lowers LH:FSH ratio, and improves insulin sensitivity in PCOS. Cardiovascular and mood benefits are additive given the comorbidity profile.
Berberine, 500 mg Three Times Daily — Insulin-Resistant Subtype
Berberine has emerging RCT evidence in PCOS-related insulin resistance, with effects comparable to metformin in some head-to-head trials. Watch for GI side effects and CYP3A4 interactions. See berberine piece.
What NOT to Take
Avoid spearmint tea as a primary anti-androgen — effect is small and inconsistent. Avoid DHEA — converts to androgens. Avoid saw palmetto for female anti-androgenic use — inadequate evidence. Skip "PCOS detox" / "hormonal cleanse" products entirely.
How to Run the Protocol
Start with inositol alone for 8 weeks; this layer does most of the work and confounds attribution if added later. Check 25-OH-D and start vitamin D dosing to target. Add NAC at week 8 if ovulation hasn't resumed. Add omega-3 from start for cardiometabolic prevention. Re-evaluate menstrual regularity, fasting insulin, and free androgen index at 6 months. Coordinate with OBGYN/RE for fertility goals and oral contraceptive considerations. See condition page.
Sources
- Teede HJ, Tay CT, Laven JJE, et al. "Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome." JCEM, 2023;108(10):2447-2469. PMID: 37580944. DOI: 10.1210/clinem/dgad463.
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. "Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials." Endocrine Connections, 2017;6(8):647-658. PMID: 29042448. DOI: 10.1530/EC-17-0243.
- Thakker D, Raval A, Patel I, Walia R. "N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis." Obstetrics and Gynecology International, 2015;2015:817849. PMID: 25653680. DOI: 10.1155/2015/817849.
- Łagowska K, Bajerska J, Jamka M. "The role of vitamin D oral supplementation in insulin resistance in women with polycystic ovary syndrome." Nutrients, 2018;10(11):1637. PMID: 30400199. DOI: 10.3390/nu10111637.
- Yang K, Zeng L, Bao T, Ge J. "Effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis." Reproductive Biology and Endocrinology, 2018;16(1):27. PMID: 29580257. DOI: 10.1186/s12958-018-0346-x.